Christopher Posner - 02 Feb 2023 Form 4 Insider Report for Cara Therapeutics, Inc. (CARA)

Role
President and CEO, Director
Signature
/s/Darren DeStefano, Attorney-in-Fact
Issuer symbol
CARA
Transactions as of
02 Feb 2023
Transactions value $
-$49,454
Form type
4
Filing time
03 Feb 2023, 17:38:59 UTC
Previous filing
30 Nov 2022
Next filing
03 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CARA Common Stock Sale -$49,453 -4,191 -2.25% $11.8* 182,370 02 Feb 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a "sell to cover" arrangement adopted by the Reporting Person in accordance with Rule 10b5-1 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units reported in the Form 4 filed with the Securities and Exchange Commission on November 3, 2021 and does not represent a discretionary trade by the Reporting Person.